SB269970塩酸塩

SB269970塩酸塩 化学構造式
261901-57-9
CAS番号.
261901-57-9
化学名:
SB269970塩酸塩
别名:
SB269970塩酸塩;(R)-3-((2-(2-(4-メチルピペリジン-1-イル)エチル)ピロリジン-1-イル)スルホニル)フェノール塩酸塩;SB-269970 塩酸塩;3-({2-[2-(4-メチルピペリジン-1-イル)エチル]ピロリジン-1-イル}スルホニル)フェノール;3-[[2-[2-(4-メチルピペリジン-1-イル)エチル]ピロリジン-1-イル]スルホニル]フェノール
英語名:
SB269970 HCl
英語别名:
SB-269970A;SB269970 HCl USP/EP/BP;SB269970 HClSB269970 HCl;SB-269970A|||SB269970 HCl;SB269970 HCl (SB-269970A);SB269970 hydrochloride, >=98%;SB-269970 hydrochloride, 10 mM in DMSO;SB 269970 hydrochloride, 5-HT7 receptor antagonist;(r)-3-[2-[2-(4-methylpiperidin-1-yl)ethyl]pyrrolidine-1-sulfonyl]phenol hydrochloride;(R)-3-((2-(2-(4-Methylpiperidin-1-yl)ethyl)pyrrolidin-1-yl)sulfonyl)phenol hydrochloride
CBNumber:
CB5972915
化学式:
C18H28N2O3S.ClH
分子量:
388.95
MOL File:
261901-57-9.mol
MSDS File:
SDS

SB269970塩酸塩 物理性質

貯蔵温度 :
2-8°C
溶解性:
H2O: 可溶10mg/mL、透明 (60 °C に加温)
外見 :
色:
White to off-white
旋光度(Optical Rotation):
[α]/D 75 to 90°, c =1.0 in DMSO
水溶解度 :
H2O: 10mg/mL, clear (warmed to 60 °C)
InChI:
1S/C18H28N2O3S.ClH/c1-15-7-11-19(12-8-15)13-9-16-4-3-10-20(16)24(22,23)18-6-2-5-17(21)14-18;/h2,5-6,14-16,21H,3-4,7-13H2,1H3;1H/t16-;/m1./s1
InChIKey:
XQCJOYZLWFNDIO-PKLMIRHRSA-N
SMILES:
Cl.CC1CCN(CC1)CC[C@H]2CCCN2S(=O)(=O)c3cccc(O)c3

安全性情報

WGK Germany  3
ストレージクラス 11 - Combustible Solids

SB269970塩酸塩 価格 もっと(11)

メーカー 製品番号 製品説明 CAS番号 包装 価格 更新時間 購入
富士フイルム和光純薬株式会社(wako) W01TOC1612 SB269970塩酸塩
SB 269970 hydrochloride
261901-57-9 10mg ¥80000 2024-03-01 購入
富士フイルム和光純薬株式会社(wako) W01TOC1612 SB269970塩酸塩
SB 269970 hydrochloride
261901-57-9 50mg ¥328000 2024-03-01 購入
Sigma-Aldrich Japan S7389 SB-269970 塩酸塩 powder, ≥98% (HPLC)
SB-269970 hydrochloride powder, ≥98% (HPLC)
261901-57-9 5mg ¥54600 2024-03-01 購入
Sigma-Aldrich Japan S7389 SB-269970 塩酸塩 powder, ≥98% (HPLC)
SB-269970 hydrochloride powder, ≥98% (HPLC)
261901-57-9 25mg ¥154000 2024-03-01 購入
富士フイルム和光純薬株式会社(wako) W01CAY17081
SB-269970 (hydrochloride)
261901-57-9 5mg ¥27200 2024-03-01 購入

SB269970塩酸塩 化学特性,用途語,生産方法

説明

The transduction of neurobehavioral effects by serotonin (5-hydroxy tryptamine; 5-HT) is mediated by at least seven major 5-HT receptor subtypes. SB-269970 is a potent 5-HT7A antagonist (pKi = 8.9) that demonstrates >50-fold binding selectivity over 5-HT5A and >250-fold selectivity over 5-HT1, 5-HT2, 5-HT4, 5-HT6, adrenergic α1, dopamine D2, and dopamine D3 receptors. It is also reported to block adrenergic α2 receptors in guinea pig vas deferens. SB-269970 has been used to target the 5-HT7 receptor in the study of schizophrenia-like cognitive deficits.

使用

SB 269970A is a selective 5-HT7 receptor antagonist.

一般的な説明

A selective 5-HT7 receptor antagonist. Extremely potent in vivo and in vitro. Chronic or acute (even single dose) administration of SB269970 induces functional desensitization of the 5-HT7 receptor system, which precedes changes in the receptor density. This mechanism may be responsible for the rapid antidepressant-like effect of the 5-HT7 antagonist in animal models. SB-269970 is an analogue of SB-258719 and has been shown to have at least 100 fold selectivity versus all other 5-HT receptor subtypes except the human 5-HT5A receptor (pKi values are 8.9, 7.2 and 6.0 for 5-HT7A, 5-HT5A and 5-HT1B).

SB269970塩酸塩 上流と下流の製品情報

原材料

準備製品


SB269970塩酸塩 生産企業

Global( 93)Suppliers
名前 電話番号 電子メール 国籍 製品カタログ 優位度
Haoyuan Chemexpress Co., Ltd. 021-58950125
info@chemexpress.com China 7545 61
Shanghai Aladdin Bio-Chem Technology Co.,LTD 400-6206333 13167063860
anhua.mao@aladdin-e.com China 29977 65
MedChemexpress LLC 021-58955995
sales@medchemexpress.cn United States 4853 58
Bide Pharmatech Ltd. 400-164-7117 18317119277
product02@bidepharm.com China 40000 60
LETOPHARM LIMITED +86-21-5821 5861
sales@letopharm.com China 2374 58
Sigma-Aldrich 021-61415566 800-8193336
orderCN@merckgroup.com China 51389 80
Shanghai Lollane Biological Technology Co.,Ltd. 021-52996696,15000506266 15000506266
China 4859 55
SPIRO PHARMA
eric_feng1954@126.com China 9239 55
EMMX Biotechnology LLC 888-539-0666
info@emmx.com United States 8435 60
Shanghai EFE Biological Technology Co., Ltd. 021-65675885 18964387627
info@efebio.com China 9799 58

  • 261901-57-9
  • SB-269970A
  • (R)-3-((2-(2-(4-Methylpiperidin-1-yl)ethyl)pyrrolidin-1-yl)sulfonyl)phenol hydrochloride
  • (r)-3-[2-[2-(4-methylpiperidin-1-yl)ethyl]pyrrolidine-1-sulfonyl]phenol hydrochloride
  • SB 269970A, (R)-3-[2-[2-(4-Methylpiperidin-1-yl)ethyl]pyrrolidine-1-sulfonyl]phenol hydrochloride
  • (2R)-1-[(3-Hydroxyphenyl)sulfonyl]-2-[2-(4-methyl-1-piperidinyl)ethyl]pyrrolidine monohydrochloride
  • Phenol, 3-[[(2R)-2-[2-(4-methyl-1-piperidinyl)ethyl]-1-pyrrolidinyl]sulfonyl]-, hydrochloride (1:1)
  • SB269970 hydrochloride, >=98%
  • SB269970 HClSB269970 HCl
  • SB269970 HCl USP/EP/BP
  • SB269970 HCl (SB-269970A)
  • SB-269970A|||SB269970 HCl
  • SB 269970 hydrochloride, 5-HT7 receptor antagonist
  • SB-269970 hydrochloride, 10 mM in DMSO
  • SB269970塩酸塩
  • (R)-3-((2-(2-(4-メチルピペリジン-1-イル)エチル)ピロリジン-1-イル)スルホニル)フェノール塩酸塩
  • SB-269970 塩酸塩
  • 3-({2-[2-(4-メチルピペリジン-1-イル)エチル]ピロリジン-1-イル}スルホニル)フェノール
  • 3-[[2-[2-(4-メチルピペリジン-1-イル)エチル]ピロリジン-1-イル]スルホニル]フェノール
Copyright 2017 © ChemicalBook. All rights reserved